CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 103 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 2.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $108,498,000 | +57.2% | 3,210,000 | +8.8% | 1.89% | +58.3% |
| Q1 2021 | $69,001,000 | -18.8% | 2,950,000 | 0.0% | 1.19% | -18.5% |
| Q4 2020 | $84,960,000 | -1.9% | 2,950,000 | -31.0% | 1.46% | +18.8% |
| Q3 2020 | $86,612,000 | -27.9% | 4,275,000 | +6.9% | 1.23% | -48.2% |
| Q2 2020 | $120,200,000 | +4.8% | 4,000,000 | +9.6% | 2.38% | -38.6% |
| Q1 2020 | $114,720,000 | -33.3% | 3,650,000 | 0.0% | 3.87% | -23.3% |
| Q4 2019 | $171,952,000 | – | 3,650,000 | – | 5.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $45,338,000 | 33.03% |
| Ponoi Management, LLC | 1,880,623 | $54,162,000 | 30.99% |
| VR Adviser, LLC | 4,016,873 | $115,686,000 | 17.01% |
| Column Group LLC | 2,626,631 | $75,647,000 | 6.86% |
| COMMODORE CAPITAL LP | 423,708 | $12,203,000 | 6.64% |
| GREAT POINT PARTNERS LLC | 1,024,800 | $29,514,000 | 4.79% |
| Venrock Management V, LLC | 1,557,276 | $44,850,000 | 4.23% |
| Ghost Tree Capital, LLC | 625,000 | $18,000,000 | 4.01% |
| Euclidean Capital LLC | 554,325 | $15,965,000 | 3.38% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 737,406 | $21,237,000 | 3.07% |